A PROSPECTIVE OPEN-LABEL TRIAL OF EXTENDED-RELEASE LIQUID METHYLPHENIDATE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN ADULTS WITH HIGH-FUNCTIONING AUTISM SPECTRUM DISORDER: AN INTERIM ANALYSIS

被引：0

作者：

Joshi, Gagan ^{[1
]}

Hoskova, Barbora ^{[1
]}

Fitzgerald, Maura ^{[1
]}

Ceranoglu, Tolga Atilla ^{[1
]}

Yule, Amy ^{[1
]}

Fried, Ronna S. ^{[1
]}

Galdo, Maribel ^{[1
]}

Belser, Abigail H. ^{[1
]}

Tornberg, Haley ^{[1
]}

Biederman, Joseph ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2017年 / 56卷 / 10期

关键词：

D O I：

10.1016/j.jaac.2017.09.301

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

5.18

引用

页码：S259 / S259

页数：1

共 50 条

[21] Use of Extended-Release Methylphenidate (Concerta) in Treatment of Cocaine Dependence in a Patient Presenting With Attention Deficit Hyperactivity Disorder
Imbert, Bruce
Labrune, Nathalie
Lancon, Christophe
Simon, Nicolas
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2014, 26 (03) : E49 - E50
[22] Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder
Winters, Drew E.
Fukui, Sadaaki
Leibenluft, Ellen
Hulvershorn, Leslie A.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (05) : 298 - 305
[23] Extended-release Methylphenidate Treatment and Outcomes in Comorbid Social Anxiety Disorder and Attention-deficit/Hyperactivity Disorder: 2 Case Reports
Koyuncu, Ahmet
Celebi, Fahri
Ertekin, Erhan
Kahn, David A.
JOURNAL OF PSYCHIATRIC PRACTICE, 2015, 21 (03) : 225 - 231
[24] Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: An open-label study
Gothelf, D
Gruber, R
Presburger, G
Dotan, I
Brand-Gothelf, A
Burg, M
Inbar, D
Steinberg, T
Frisch, A
Apter, A
Weizman, A
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (10) : 1163 - 1169
[25] An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder
Somoza, EC
Winhusen, TM
Bridge, TP
Rotrosen, JP
Vanderburg, DG
Harrer, JM
Mezinskis, JP
Montgomery, MA
Ciraulo, DA
Wulsin, LR
Barrett, JA
JOURNAL OF ADDICTIVE DISEASES, 2004, 23 (01) : 77 - 92
[26] An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
Childress, Ann
Cutler, Andrew J.
Adler, Lenard A.
Fry, Nicholas
Asubonteng, Kobby
Maldonado-Cruz, Zulane
Formella, Andrea
Rubin, Jonathan
CNS DRUGS, 2024, 38 (11) : 891 - 907
[27] Maintenance of response after open-label treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder
Upadhyaya, H.
Ramos-Quiroga, J. A.
Williams, D.
Tanaka, Y.
Lane, J. R.
Escobar, R.
Trzepacz, P.
Camporeale, A.
Allen, A. J.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S427 - S428
[28] Does OROS*-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder
Fallu, Angelo
Richard, Caroline
Prinzo, Rosanna
Binder, Carin
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (12) : 2557 - 2566
[29] Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: An interim analysis
Adler, LA
Spencer, TJ
Milton, DR
Moore, RJ
Michelson, D
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (03) : 294 - 299
[30] Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder
Zheng Yi
Wang Yu-feng
Qin Jiong
Wang Li-wen
Zou Li-ping
Jin Xing-ming
Xu Tong
Wang Yi
Qi Yuan-li
Gong Mei-en
Yin Qing-yun
Mai Jian-ning
Jing Jin
Luo Xiang-yang
Ma Hong-wei
Li Hai-bo
Xie Ling
Li Yan
Kuang Gui-fang
Yi Ming-ji
Wang Feng
Zhu Xiao-hua
Yao Yan-bin
CHINESE MEDICAL JOURNAL, 2011, 124 (20) : 3269 - 3274

← 1 2 3 4 5 →